HTA - Health Technology Assessment Report Colistimethate sodium powder for inhalation (Colobreathe) for pseudomonas aeruginosa lung infection in cystic fibrosis Year: 2009 Date: 12 May 2010 Author: National Horizon Scanning Centre Source Birmingham: National Horizon Scanning Centre (NHSC) YR: 2009 Participants CF patients with Pseudomonas aeruginosa lung infection (including colonisation) Interventions Colistimethate sodium powder for inhalation (Colobreathe) administered twice daily